What top creators are saying about Agenus Inc.(AGEN)
Clinical-stage immuno-oncology company.
2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Agenus Inc..
Top creators covering Agenus Inc. (AGEN)
The 1 sources with the most insights about Agenus Inc. on Kazuha.
Latest insights about Agenus Inc. (AGEN)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Tuesday, July 21, 2026
Host shorted AGEN twice during the episode, actively trading from the short side, momentum short.
Monday, July 13, 2026
Characterized as a 'dead biotech' with inferior mechanisms; price spike viewed as a dead cat bounce with a short opportunity toward the $3.00-$3.50 range.
Tuesday, July 21, 2026
Host shorted AGEN twice during the episode, actively trading from the short side, momentum short.
Monday, July 13, 2026
Characterized as a 'dead biotech' with inferior mechanisms; price spike viewed as a dead cat bounce with a short opportunity toward the $3.00-$3.50 range.
Discussed alongside Agenus Inc. (AGEN)
Other assets that creators frequently mention in the same content as Agenus Inc..
Frequently asked
Which podcasters and creators cover Agenus Inc. (AGEN) the most?
The most active sources covering Agenus Inc. (AGEN) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Agenus Inc. (AGEN) are on Kazuha?
Kazuha has indexed 2 AI-extracted insights about Agenus Inc. (AGEN) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Agenus Inc. (AGEN)?
Creators covering Agenus Inc. (AGEN) most frequently also discuss MU, AAPL, WDC, UTZ, AMC. See the "Discussed alongside" section above for full asset pages.